Josipovic, I.; Pflueger, B.; Fork, C.; Vasconez, A. E.; Oo, J. A.; Hitzel, J.; Seredinski, S.; Gamen, E.; zu Heringdorf, D. M.; Chen, W.et al.; Looso, M.; Pullamsetti, S. S.; Brandes, R. P.; Leisegang, M. S.: Long noncoding RNA LISPR1 is required for S1P signaling and endothelial cell function. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 116, pp. 57 - 68 (2018)
Gamen, E.; Seeger, W.; Pullamsetti, S. S.: The emerging role of epigenetics in pulmonary hypertension. EUROPEAN RESPIRATORY JOURNAL 48 (3), pp. 903 - 917 (2016)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).